Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
A very wet and windy day today, the wind being the main issue. We widely expect gusts of 60mph, even inland, with travel disruption possible
Winds strengthening overnight, gusts of 60mph by Tuesday morning, 70mph at the coast - possible disruption to travel and energy services
A 15-year-old girl has died after she collapsed while playing in a football match in Lancashire.